11 news items
NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK.
NUTX
24 May 24
developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection
NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
NUTX
8 May 24
, conflicts
NUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
NUTX
7 May 24
, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETING
NUTX
6 May 24
and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions
NUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCE
NUTX
29 Apr 24
, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects
s87z7tj0iziceg47s66vg9l2tycxlc rzypljz8uryu2ljfvthpfan9a9r
NUTX
22 Apr 24
ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards
q19rbgsn7fmph9um73czqnowdrllkz941c3qpx9mogae84c182p4ci1nah
NUTX
16 Apr 24
ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards
4716a7wkod0de9jsujim qhwwkyrd96snv1xz3x6dckdndvaai58ojr
NUTX
12 Apr 24
of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory
kkcmh8sxo3ns21q2dj9djlbj76ncg v8cvrddfqh1
NUTX
8 Apr 24
developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection
qmrj6y241q7lkqsq1kblb
NUTX
5 Apr 24
and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related
duxf6vau do
NUTX
28 Mar 24
, conflicts
- Prev
- 1
- Next